Recent Posts

Monarch Innovation Partner's new peer-reviewed Perspective Paper has been published in the Journ

Monarch Innovation Partners Presenting at the 1st International Caparica Congress on Leishmaniasis

Monarch Innovation Partner's was selected to participate in the 2018 NIH mHealth Technology Show

Editorial published in the Journal of Digital Medicine: The power of digital medicine to support sel

Monarch Innovation Partners a Member of the NIH-National Kidney Disease Education Program's Elec

Monarch Innovation Partners presents at the 1st Workshop “NanoBioMed Sardinia 2017” , which took pla

Monarch Innovation Partners leads co-authorship of in-depth, systematic review of health disparities

Monarch Innovation Partners leads co-authorship of systematic review related to health disparities a

Monarch Innovation Partners leads co-authorship of the American Journal of Nephrology three-part ser

Original Research: Global Health Innovation Technology Models: Published in the Journal of Nanobiome

Monarch Innovation Partners presents at the 1st Workshop “NanoBioMed Sardinia 2017” , which took pla

Kimberly Harding, President and Founder of Monarch Innovation Partners, presented her original research and conceptual platform, Project Orchid. Her topic, “Project Orchid – An Open Science-Open Source technology framework for sustainable global health innovation partnerships associated with Precision Medicine cohorts for infectious and chronic disease interrogation initiatives”, was presented at the venue. The workshop covered the following topics related to different nanomaterials, in particular carbon nanomaterials such as carbon nanotubes and graphene. Sessions also included the following: synthesis, processing and multiscale characterization for medical applications, bone regeneration, neuroscience cardiology, nanotoxicology and cancer.